Where I would invest $5,000 in the share market

If I had $5,000 to invest I would consider putting it in the shares of CSL Limited (ASX:CSL) and…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

While $5,000 might not sound like it could be a life-changing amount of money to invest, if you can afford to invest this sum of money on an annual basis for an extended period it certainly could be.

According to Fidelity, the local share market has provided an average annual return of 9.8% over the last three decades.

This means that if you had invested $5,000 each year over the last 30 years it would have grown to be worth just short of $875,000 today. Two years later, if the returns stayed the same, this figure would have made you a millionaire with a small fortune of approximately $1,065,000.

While there is no guarantee that the market will provide the same level of return over the next three decades, I'm optimistic that it will.

With that in mind, here are two shares which I think could provide market-beating returns over the long term:

CSL Limited (ASX: CSL)

CSL is a global biotech company which I believe is one of the best buy and hold investment options on the Australian market. This high-quality company has been a consistently strong performer over the long term and shows no signs of breaking the trend in the near future. During August the company reported its full year results and posted a 15% increase in revenue to US$7.6 billion and a 29% jump in net profit after tax to US$1.73 billion. Management appears confident that its positive performance will continue in FY 2019 and has provided guidance of net profit after tax in the range of US$1,880 million to US$1,950 million.

Xero Limited (ASX: XRO)

Xero is an accounting software company growing at an impressively strong rate thanks to the increasing popularity of its high-quality product. At the last count there were 1.4 million users of its software, putting the company on an annualised monthly recurring revenue (AMRR) of $484.4 million. These subscriber numbers could be given a major lift if it can successfully penetrate the massive U.S. market. While progress has been slower than many had expected, I believe in time it will carve out a meaningful slice of the lucrative market. I think Xero is a standout pick in the industry and a far better option than rivals MYOB Group Ltd (ASX: MYO) and Reckon Limited (ASX: RKN).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »

Part of male mannequin dressed in casual clothes holding a sale paper shopping bag.
Growth Shares

2 ASX financial stocks that could double – or even triple – in value

If sentiment turns and execution delivers, this could be an opportunity investors won’t want to miss.

Read more »